Journal
PIGMENT CELL & MELANOMA RESEARCH
Volume 21, Issue 4, Pages 415-428Publisher
WILEY
DOI: 10.1111/j.1755-148X.2008.00478.x
Keywords
G-protein-coupled-receptors; oncogenes; melanocytes; melanoma
Categories
Funding
- NCI NIH HHS [R01 CA108720, R01 CA108720-05, R01CA74077] Funding Source: Medline
- NIEHS NIH HHS [P30 ES005022, ES05022] Funding Source: Medline
Ask authors/readers for more resources
G-protein-coupled receptors (GPCR) are the largest family of receptors with over 500 members. Evaluation of GPCR gene expression in primary human tumors identified over-expression of GPCR in several tumor types. Analysis of cancer samples in different disease stages also suggests that some GPCR may be involved in early tumor progression and others may play a critical role in tumor invasion and metastasis. Currently, > 50% of drug targets to various human diseases are based on GPCR. In this review, the relationships between several GPCR and melanoma development and/or progression will be discussed. Finally, the possibility of using one or more of these GPCR as therapeutic targets in melanoma will be summarized.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available